Breaking News

Coriolis Pharma Invests in New Campus

The CRDO is expanding its current headquarters with additional facilities to form a new campus in Martinsried-Munich.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Coriolis Pharma, a contract research and development organization (CRDO), is expanding its current headquarters to form a new campus as the next step in its growth strategy. Located in the heart of the biotech hotspot Martinsried, the new Coriolis campus will double the overall capacities to 14,000 square meters. It will include two new buildings (Fraunhoferstrasse 14 and F14b), the current headquarters (F18b) and two additional locations (F8 and F11a). The new campus with interconnected buil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters